PureFunds ETFx HealthTech ETF
IMED
IMED was delisted on the 6th of September, 2017.
0 hedge funds and large institutions have $0 invested in PureFunds ETFx HealthTech ETF in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.34M → $0 (-$1.34M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$1.34M |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| – | -$1.34M | -44,822 | Closed |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| – | -$6K | -196 | Closed |
|
IMED Hedge Fund Activity: Q3 2017 in Review
0 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PureFunds ETFx HealthTech ETF (IMED) for Q3 2017, worth a combined $0 — down 100% from $1.34M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of IMED and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $1.34M sold.
- 0 institutional investors held PureFunds ETFx HealthTech ETF (IMED) as of Q3 2017, down from 2 in Q2 2017.
- Funds reported $0 of PureFunds ETFx HealthTech ETF stock for Q3 2017, down 100% quarter-over-quarter.
- 0 funds opened new PureFunds ETFx HealthTech ETF positions in Q3 2017 and 2 closed out, a net change of -2 holders.
- The largest PureFunds ETFx HealthTech ETF seller in Q3 2017 was Jane Street, an estimated $1.34M sold.
Based on aggregated 13F filings for Q3 2017.